Cytek Biosciences has signed an agreement with the Centre for Genomic Regulation, or CRG, and the Pompeu Fabra University, or UPF, to drive technological innovation and accelerate discoveries for the scientific community. Under the terms of the agreement, Cytek will provide new spectral cytometry platforms – along with trained support personnel – to the CRG-UPF Flow Cytometry Unit’s headquarters. The Unit, founded in 2001 and based in the Barcelona Biomedical Research Park, is a worldwide reference site for advanced flow cytometry applications.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CTKB:
- Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
- Cytek Biosciences expects FY23 revenue near high end of $188M-$192M guidance
- Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
- Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
- Cytek Biosciences introduces Cytek Orion reagent cocktail preparation system